Antifungal Drug Market Forecast to Show Spurring Growth by 2016-2024 – ZMR News Magazine

Antifungal Drug Market Forecast to Show Spurring Growth by 2016-2024

Major players working in the global antifungal drug market comprise Alternaria, Asperqillus, Pfizer, Abbott Laboratories, Bayer Healthcare, Glaxosmithkline, Sanofi-Aventis, Novartis, Kramer Laboratories, Merck & Co., Gilead, and Enzon Pharmaceuticals. These players are claimed to take the global antifungal drug market to new heights in the coming period.

Request Brochure of Antifungal Drug Market Report for more Industry Insights CLICK HERE NOW

As per analysts at Zion Market Research, the global antifungal drug market added up for almost USD 11.30 Billion in 2015 and is likely to cross almost USD 14.10 Billion by the end of 2021, developing at a CAGR of almost 3.6% from 2015 to 2021.

Compromised Immune System And Torpid Lifestyle To Power The Global Antifungal Drug Market In The Forecast Period

The antifungal drug market is mainly boosted by rising prevalence of fungal infection all over the world, as per analysts at Zion Market Research. In addition to this, rising awareness is a primary factor that is likely to market the development of antifungal drug market. Furthermore, the compromised immune system and torpid lifestyle can impact the antifungal drug market. On the other hand, huge penetration of conservative medication paired with the conventional approach of therapy is the major limiting for the development of antifungal drug market.

Nevertheless, in-progress R&D in developing anti fungal drugs is expected to bring growth opportunities in the future for the antifungal drug market. For instance, in August 2018, a research was conducted by the scientists that proved azole antifungals restrain the pathway for fungal ergosterol biosynthesis. This leads to either killing of the pathogen or increasing inhibition relying on the species.

Speedy Spread Of Fungal Infection To Maintain The Dominance Of Asia Pacific In Antifungal Drug Market In Years To Come

In terms of topography, North America was the top area for antifungal drug market in terms of income in 2015. This development is supported by broad awareness related to fungi associated infection. North America added up for almost over USD 4.20 Billion in 2015 which is almost over 35% of world total for antifungal drug market. In addition to this, lifestyle-associated factors such as torpid sedentary lifestyle have turned out to be very common in European nations and the U.S., which result in weakening the immune system and thus pace the fungal infections, boosting the antifungal drug market. Asia Pacific is likely to be the quickest area for the antifungal drug market in the years to come due to the speedy spread of fungal infection in this area.

Get Sample of Antifungal Drug Market Report for more Industry Insights @ CLICK HERE NOW

On the basis of the dosage form, the global antifungal drug market is divided into 4 types such as ointments, powders, pastes, and drugs. Ointment and powder dosage form ruled the antifungal drug market in 2015. The development is credited due to easy accessibility of antifungal drug products in the medical shops.

The global antifungal drug market is segmented as follows:

By Type

  • Echinocandins
  • Azoles
  • Polyenes
  • Allylamines
  • Others

By Therapeutic

  • Aspergillosis
  • Dermatophytosis
  • Candidiasis
  • Others

By Dosage

  • Powders
  • Ointments
  • Drugs
  • Pastes

Inquiry more about this report @ CLICK HERE NOW

By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Comments are closed.